Stopping GLP-1 therapy may disrupt glycemic control and reduce cardiovascular benefits without clear perioperative safety ...
MOVE-IT met the primary endpoint with statistically significant improvement in gastroparesis symptoms in 20 mg and 40 mg TID ...
Patients on semaglutide who experienced constipation had greater weight loss than those without constipation, and genes could be at play.
According to Johannah Katz, RD, a registered dietitian from Consumer Health Digest, earlier dinners can majorly affect ...
Experts warn popular GLP‑1 drugs may pose added risks for some patients, highlighting the need for medical supervision.
Dr Anukalp Prakash explains how watermelon consumption affects post-meal bloating. Here are some tips to consume it so it ...
The FDA also asked Lilly to conduct a milk-only lactation study in women who have received a dose to assess concentrations of the drug in breast milk.
The U.S. Food and Drug Administration has asked Eli Lilly for more data on liver injury linked to its newly approved obesity ...
Cannabis use may impact glycemic control by impairing self-management behaviors and delaying gastric emptying among patients ...
Giant migrating contractions (GMCs) are powerful waves of colonic movement that propel intestinal contents toward the anus and are essential for defecation. Yet despite their physiological importance, ...
Brain fog is the result of “bad connections” between the gut and the brain, said Gerard Clarke, a professor of ...
From side effects to misuse, what patients should know before using GLP-1 weight-loss drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results